Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02549105|
Recruitment Status : Unknown
Verified September 2015 by HANY AYAD IBRAHIM, Ain Shams Maternity Hospital.
Recruitment status was: Recruiting
First Posted : September 15, 2015
Last Update Posted : September 15, 2015
|Condition or disease||Intervention/treatment||Phase|
|Post Operative Pain||Drug: EMLA CREAM 5 mg Drug: LIDOCAINE 1 %||Phase 4|
The purpose of this study is to compare the effectiveness of topically applied lidocaine-prilocaine (EMLA) cream with local anesthetic (lidocaine) infiltration on post-cesarean section pain.
Is lidocaine-prilocaine (EMLA) cream application effective as compared to local anesthetic (lidocaine) infiltration on post-caesarean section pain?
Lidocaine-prilocaine (EMLA) cream application is effective in post_caesarean section pain as compared to local anesthetic (lidocaine) infiltration.
Clinical Application :
Topical Lidocaine-prilocaine (EMLA) cream could be applied frequent times postoperatively, unlike infiltration with local anesthetic.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And Wound Infiltration With Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial|
|Study Start Date :||October 2014|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||December 2015|
Active Comparator: EMLA CREAM
EMLA CREAM 5 mg TOPICAL APPLICATION FOR CS WOUND AND ASSESSMENT FOR POST OPERATIVE PAIN IN FIRST 6 HOURS
Drug: EMLA CREAM 5 mg
EMLA CREAM APPLICATION FOR WOUND AFTER CS
Other Name: EMLA CREAM, PRILOCAIN 25 LIDOCAIN 25
Active Comparator: LIDOCAINE INFILTERATION
LIDOCAINE 1 % 20 ml INFILTERATION FOR WOUND AND ASSESSMENT OF POST OPERATIVE PAIN IN FIRST 6 HOURS
Drug: LIDOCAINE 1 %
LIDOCAINE 1 % INFILTERATION FOR WOUND AND ASSESSMENT OF PAIN IN FIRST 6 HOURS
Other Name: XYLOCAINE
- TIME TO THE FIRST DOSE OF RESCUE ANALGESIC IN THE FIRST 6 HOURS [ Time Frame: 6 H ]
- POSTOPERATIVE PAIN ACCORDING TO VAS [ Time Frame: 24 H ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02549105
|Contact: HANY A IBRAHIM, MBBCH||01220034468||DR.HANY_AYAD@YAHOO.COM|
|Contact: AHMED M MAMDOUH, MD|
|Ain Shams university Maternity hospital||Recruiting|
|Cairo, Abbasya, Egypt, 11821|
|Contact: Maged R Aboseda, professor 00201069190707 firstname.lastname@example.org|
|Principal Investigator:||MAGED R ABO SAEDA, MD||AIN SHAMS MATERNAL HOSPITAL|